...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study

Thanks.  It sounded like good news and ultimately in the future will move the share price.  Keeps me hanging on.

Share
New Message
Please login to post a reply